Belpointe Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-35,648
Closed -$531K 1003
2025
Q1
$531K Buy
+35,648
New +$548K 0.03% 547
2023
Q2
Sell
-1,086
Closed -$25.5K 2434
2023
Q1
$25.5K Buy
1,086
+87
+9% +$2.34K ﹤0.01% 2162
2022
Q4
$27.9K Buy
+999
New +$25.5K ﹤0.01% 1958
2022
Q3
Sell
-7,852
Closed -$265K 1218
2022
Q2
$265K Sell
7,852
-310
-4% -$10.9K 0.02% 722
2022
Q1
$285K Sell
8,162
-128
-2% -$4.38K 0.02% 753
2021
Q4
$254K Buy
8,290
+676
+9% +$22K 0.02% 795
2021
Q3
$250K Buy
+7,614
New +$244K 0.02% 772

Other funds holding OGN

Belpointe Asset Management's OGN Position: Q2 2025 in Review

Belpointe Asset Management sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 35,648 shares — an estimated $531K sold.

Belpointe Asset Management first reported a position in OGN in Q3 2021 and held it in 7 quarters. The position peaked at $531K in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Belpointe Asset Management reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Belpointe Asset Management sold 35,648 Organon & Co shares in Q2 2025, an estimated $531K.
  • Belpointe Asset Management first reported a position in Organon & Co in Q3 2021 and held it in 7 quarters.
  • Belpointe Asset Management's Organon & Co position peaked at $531K in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Belpointe Asset Management's 13F filing for Q2 2025, filed 22 Jul 2025.